BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 112 filers reported holding BIOSCRIP INC in Q2 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $336,000 | -23.1% | 168,200 | -59.9% | 0.07% | -25.0% |
Q4 2016 | $437,000 | -93.2% | 419,831 | -81.2% | 0.09% | -93.3% |
Q3 2016 | $6,467,000 | +13.3% | 2,237,608 | 0.0% | 1.38% | +0.4% |
Q2 2016 | $5,706,000 | +115.5% | 2,237,608 | +80.8% | 1.37% | +118.1% |
Q1 2016 | $2,648,000 | +94.6% | 1,237,608 | +59.1% | 0.63% | +101.9% |
Q4 2015 | $1,361,000 | -68.2% | 777,920 | -66.1% | 0.31% | -69.8% |
Q3 2015 | $4,285,000 | -23.2% | 2,291,529 | +49.1% | 1.03% | -6.9% |
Q2 2015 | $5,577,000 | -43.0% | 1,536,469 | -30.4% | 1.11% | -43.5% |
Q1 2015 | $9,785,000 | -37.1% | 2,208,710 | -0.8% | 1.96% | -22.7% |
Q4 2014 | $15,564,000 | +7.7% | 2,226,561 | +6.5% | 2.54% | -10.8% |
Q3 2014 | $14,447,000 | -17.1% | 2,090,789 | 0.0% | 2.85% | -7.1% |
Q2 2014 | $17,437,000 | +2.4% | 2,090,789 | -14.3% | 3.07% | -4.5% |
Q1 2014 | $17,023,000 | -5.7% | 2,438,846 | 0.0% | 3.21% | -6.3% |
Q4 2013 | $18,047,000 | +91.8% | 2,438,846 | +127.6% | 3.43% | +71.8% |
Q3 2013 | $9,408,000 | +15.5% | 1,071,560 | +117.1% | 2.00% | +4.4% |
Q2 2013 | $8,143,000 | – | 493,503 | – | 1.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |